Welcome
The BCLC at the Hospital Clínic of Barcelona is a multidisciplinary team involving all relevant medical specialities devoted to clinical care, research and education in the field of liver cancer. It combines state of the art diagnosis and therapy, with the development of several research projects to evaluate new treatment options. These include laboratory studies in cell cultures or animal models and clinical trials in patients with liver cancer.


Short term fellowships
Recent Publications

JOURNAL ARTICLE
Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution.

Reig, M
, Mariño, Z, Perelló, C, Iñarrairaegui, M, Ribeiro, A, Lens, S, Díaz, A, Vilana, R, Darnell, A, Varela, M, Sangro, B, Calleja, J.L, Forns, X, Bruix, J

Journal of Hepatology 2016;:doi: 10.1016/j.jhep.2016.04.008
Pubmed abstract
JOURNAL ARTICLE
Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH

Alejandro Forner
, María Reig, María Varela, Marta Burrel, Jaime Feliu, Javier Briceno, Javier Sastre, Luis Martí-Bonmati, Josep María Llovet, José Ignacio Bilbao, Bruno Sangro, Fernando Pardo, Carmen Ayuso, Concepció Bru, Josep Tabernero y Jordi Bruix

Medicina Clínica 2016;:doi: 10.1016/j.medcli.2016.01.028
Pubmed abstract
JOURNAL ARTICLE
Evidence-based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma

Bruix J
, Reig M, Sherman M.
Gastroenterology 2016;:doi: 10.1053/j.gastro.2015.12.041
Pubmed abstract
JOURNAL ARTICLE
Sorafenib or Placebo plus TACE with Doxorubicin-Eluting Beads for Intermediate-Stage HCC: Phase II, Randomized, Double-Blind SPACE Trial.
Lencioni R, Llovet JM, Han G, Tak WY, Yang J, Guglielmi A, Paik SW, Reig M, Kim DY, Chau GY, Luca A, Del Arbol LR, Leberre MA, Niu W, Nicholson K, Meinhardt G, Bruix J.

Journal of Hepatology 2016;:doi: 10.1016/j.jhep.2016.01.012
Pubmed abstract
JOURNAL ARTICLE
Prospective validation of "ab initio" liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.
Ferrer-Fàbrega J, Forner A, Liccioni A, Miquel R, Molina V, Navasa M, Fondevila C, García-Valdecasas JC, 
Bruix J, Fuster J. Hepatology 2015;doi: 10.1002/hep.28339
Pubmed abstract